Dendrimers in the context of targeting central nervous system disorders

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Journal of Drug Delivery Science and Technology

• Publication date

  2022-05-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.jddst.2022.103474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effectiveness of CAPE in reducing vascular permeability after brain injury

  2021cited by this paper
• Biomimetic Dendrimer–Peptide Conjugates for Early Multi‐Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation

  2021cited by this paper
• First-in-class and best-in-class dendrimer nanoplatforms from concept to clinic: Lessons learned moving forward.

  2021cited by this paper
• Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies using colloidal carrier systems.

  2021cited by this paper
• Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson’s Disease Patient-Specific Dopamine Neurons

  2021cited by this paper
• Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro

  2021cited by this paper
• PAMAM dendrimers with dual-conjugated vancomycin and Ag-nanoparticles do not induce bacterial resistance and kill vancomycin-resistant staphylococci.

  2021cited by this paper
• Long non-coding RNA H19: physiological functions and involvements in central nervous system disorders.

  2021cited by this paper
• Central nervous system delivery of molecules across the blood-brain barrier.

  2021cited by this paper
• Dendrimer-based nanohybrids in cancer photomedicine

  2021cited by this paper
• Synthesis, characterization and applications of poly-aliphatic amine dendrimers and dendrons

  2020cited by this paper
• Theranostic lyotropic liquid crystalline nanostructures for selective breast cancer imaging and therapy.

  2020cited by this paper
• Non-Invasive Strategies for Nose-to-Brain Drug Delivery

  2020cited by this paper
• Targeted systemic dendrimer delivery of CSF‐1R inhibitor to tumor‐associated macrophages improves outcomes in orthotopic glioblastoma

  2020cited by this paper
• Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells

  2020cited by this paper
• Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury

  2020cited by this paper
• A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity

  2020cited by this paper
• Gold liposomes for brain-targeted drug delivery: Formulation and brain distribution kinetics.

  2020cited by this paper
• Brain gene delivery using histidine and arginine-modified dendrimers for ischemic stroke therapy.

  2020cited by this paper
• Etoposide and olaparib polymer-coated nanoparticles within a bioadhesive sprayable hydrogel for post-surgical localised delivery to brain tumours.

  2020cited by this paper
• A review on synthesis and applications of dendrimers

  2020cited by this paper
• Linezolid as salvage therapy for central nervous system infections due to methicillin-resistant Staphylococcus aureus at two medical centers in Taiwan.

  2020cited by this paper
• Targeting Mitochondria in Tumor-Associated Macrophages using a Dendrimer Conjugated TSPO Ligand Stimulates Anti-Tumor Signaling in Glioblastoma.

  2020cited by this paper
• Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent.

  2020cited by this paper
• Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders

  2020cited by this paper
• Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injury.

  2020cited by this paper
• Prevalence and Diagnosis of Neurological Disorders Using Different Deep Learning Techniques: A Meta-Analysis

  2020cited by this paper
• Polyamidoamine (PAMAM) dendrimers synthesis, characterization and adsorptive removal of nickel ions from aqueous solution

  2020cited by this paper
• Changes in macrophage inflammatory protein-1 (MIP-1) family members expression induced by traumatic brain injury in mice.

  2020cited by this paper
• Combined Therapy for Alzheimer’s Disease: Tacrine and PAMAM Dendrimers Co-Administration Reduces the Side Effects of the Drug without Modifying its Activity

  2020cited by this paper
• Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration

  2020cited by this paper
• Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury.

  2020cited by this paper
• Neurological Implications of COVID-19 Infections

  2020cited by this paper
• Starburst pamam dendrimers: Synthetic approaches, surface modifications, and biomedical applications

  2020cited by this paper
• CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

  2019cited by this paper
• Blood-Brain Barrier: From Physiology to Disease and Back.

  2019cited by this paper
• Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications

  2019cited by this paper
• Application of new lysine-based peptide dendrimers D3K2 and D3G2 for gene delivery: Specific cytotoxicity to cancer cells and transfection in vitro.

  2019cited by this paper
• Cognitive symptoms of Alzheimer’s disease: clinical management and prevention

  2019cited by this paper
• Dendrimers in the context of nanomedicine.

  2019cited by this paper
• Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer's Disease in Mice.

  2019cited by this paper
• Biodistribution and Biosafety of a Poly(Phosphorhydrazone) Dendrimer, an Anti-Inflammatory Drug-Candidate

  2019cited by this paper
• A novel PEGylated carbon nanotube conjugated mangiferin: An explorative nanomedicine for brain cancer cells

  2019cited by this paper
• An innovative In-situ method of creating hybrid dendrimer nano-assembly: An efficient next generation dendritic platform for drug delivery.

  2019cited by this paper
• Generation 2 (G2) - Generation 4 (G4) PAMAM dendrimers disrupt key plasma coagulation parameters.

  2019cited by this paper
• Parkinson's disease: Mechanisms, translational models and management strategies

  2019cited by this paper
• Cytotoxicity of Dendrimers

  2019cited by this paper
• Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection.

  2019cited by this paper
• Emerging Treatment Approaches for Parkinson’s Disease

  2018cited by this paper
• Pediatric oral formulation of dendrimer-N-acetyl-l-cysteine conjugates for the treatment of neuroinflammation.

  2018cited by this paper
• Possible strategies to cross the blood–brain barrier

  2018cited by this paper
• Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model

  2018cited by this paper
• Dendrimers: A versatile nanocarrier for drug delivery and targeting

  2018cited by this paper
• Tau Protein Squired by Molecular Chaperones During Alzheimer’s Disease

  2018cited by this paper
• Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics

  2018cited by this paper
• PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization

  2018cited by this paper
• Beyond the Blood–Brain Barrier

  2018cited by this paper
• A Multidimensional Approach to Post-concussion Symptoms in Mild Traumatic Brain Injury

  2018cited by this paper
• Cancer statistics, 2018

  2018cited by this paper
• Neuro-oncology in 2016: Advances in brain tumour classification and therapy

  2017cited by this paper
• Cyclooxygenase-2 in glioblastoma multiforme.

  2017cited by this paper
• Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules

  2017cited by this paper
• Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues

  2017cited by this paper
• The influence of surface functionality of poly(propylene imine) dendrimers on aggregation and propagation of the scrapie prion protein

  2017cited by this paper
• Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update

  2017cited by this paper
• β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease

  2017cited by this paper
• Construction of core-shell tecto dendrimers based on supramolecular host-guest assembly for enhanced gene delivery.

  2017cited by this paper
• Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

  2017cited by this paper
• Neuro-nutraceuticals: Further insights into their promise for brain health.

  2016cited by this paper
• A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.

  2016cited by this paper
• Differences in toxicity of anionic and cationic PAMAM and PPI dendrimers in zebrafish embryos and cancer cell lines.

  2016cited by this paper
• Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.

  2016cited by this paper
• Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery.

  2016cited by this paper
• Use of ‘click chemistry’ for the synthesis of carbohydrate-porphyrin dendrimers and their multivalent approach toward lectin sensing

  2016cited by this paper
• Dendrimers Target the Ischemic Lesion in Rodent and Primate Models of Nonarteritic Anterior Ischemic Optic Neuropathy

  2016cited by this paper
• Nanoscale effects in dendrimer-mediated targeting of neuroinflammation.

  2016cited by this paper
• Blood-brain barrier transport machineries and targeted therapy of brain diseases

  2016cited by this paper
• The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

  2016cited by this paper
• Microglia in the TBI brain: The good, the bad, and the dysregulated.

  2016cited by this paper
• Neurodegenerative diseases: expanding the prion concept.

  2015cited by this paper
• Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer’s Disease

  2015cited by this paper
• CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.

  2015cited by this paper
• Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury.

  2015cited by this paper
• Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease

  2015cited by this paper
• Phosphorus dendrimers and photodynamic therapy. Spectroscopic studies on two dendrimer-photosensitizer complexes: Cationic phosphorus dendrimer with rose bengal and anionic phosphorus dendrimer with methylene blue.

  2015cited by this paper
• Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery.

  2015cited by this paper
• Optimization of dendrimer structure for sentinel lymph node imaging: Effects of generation and terminal group.

  2015cited by this paper
• Cationic phosphorus dendrimers and therapy for Alzheimer's disease

  2015cited by this paper
• Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer.

  2014cited by this paper
• Interaction of Astramol poly(propyleneimine) dendrimers with DNA and poly(methacrylate) anion in water and water-salt solutions.

  2014cited by this paper
• Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues

  2014cited by this paper
• Dendrimer as nanocarrier for drug delivery

  2014cited by this paper
• Dendrimers: synthesis, applications, and properties

  2014cited by this paper
• Synthesis of novel polyesteramine dendrimers by divergent and convergent methods

  2013cited by this paper
• Novel 'Si-C' carbosilane dendrimers as carriers for anti-HIV nucleic acids: studies on complexation and interaction with blood cells.

  2013cited by this paper
• The blood-brain barrier: an engineering perspective

  2013cited by this paper
• Deep brain stimulation for Parkinson's disease and other movement disorders.

  2013cited by this paper
• Demystifying brain penetration in central nervous system drug discovery. Miniperspective.

  2013cited by this paper
• Inflammation and white matter degeneration persist for years after a single traumatic brain injury.

  2013cited by this paper
• Dendrimers and their Applications as Novel Drug Delivery Carriers

  2013cited by this paper

• Advancing Drug Solubility and Precision Delivery with Next-Generation Nanocarriers: Recent Innovations, Opportunities, and Challenges

  2026cites this paper
• Therapeutic Dendrimers: a Nanotechnology Approach to Alzheimer’s Disease

  2025cites this paper
• Lactate-coated polyurea-siRNA dendriplex: a gene therapy-directed and metabolism-based strategy to impair glioblastoma (GBM)

  2025cites this paper
• Exploring the Applications of Molecularly Imprinted Polymers in Drug Delivery to the Nervous System

  2025cites this paper
• Synthesis and Characterization of Free Radical Scavenging Dendrimer Nanogels via Cross-Linking Reaction-Enabled Flash Nanoprecipitation.

  2025cites this paper
• Targeting Alzheimer’s disease pathology: influence of nano-based drug delivery systems loaded with a combination of herbal and synthetic drugs

  2025cites this paper
• Dendrimers for Drug Delivery: An Overview of its Classes, Synthesis, and Applications

  2024cites this paper
• Nanocarriers in the Treatment of Epilepsy: Challenges and Opportunities

  2024cites this paper
• Advancements in neurotherapeutics: nanoparticles overcoming the blood–brain barrier for precise CNS targeting

  2024cites this paper
• Alzheimer’s Disease Pathology and Assistive Nanotheranostic Approaches for Its Therapeutic Interventions

  2024cites this paper
• Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders

  2023cites this paper
• Current and Future Directions of Drug Delivery for the Treatment of Mental Illnesses.

  2023cites this paper
• Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics.

  2022cites this paper
• Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease

  2022cites this paper
• Dendrimer-based delivery of macromolecules for the treatment of brain tumor.

  2022cites this paper